Department profile
Goodwin Procter LLP

Securities: Litigation

USA Guide 2026 : USA - Nationwide


Goodwin Procter LLP

About

Provided by Goodwin Procter LLP

When a company is faced with a securities class action or shareholder derivative litigation, they need a partner who understands what is at stake and can think outside the box to achieve resolution. Goodwin’s deep experience, creative thinking and tenacity has led to our involvement in precedent-setting securities cases in courts across the country. The results we achieve are best of breed and have helped shape the law nationally, including outright dismissals of billions of dollars in putative class action and shareholder derivative claims. Our cases range from defending high tech and biotech companies in class action securities fraud litigation brought following restatements of earnings or the release of bad business news, to resolving shareholder derivative challenges, to multibillion dollar mergers and acquisitions. 

We have in-depth experience handling securities class actions, shareholder derivative litigation, M&A litigation, and private equity and portfolio company litigation. We also work hand-in-hand with our Enforcement + Government Investigations practice on SEC enforcement actions and state agency investigations, responding to investigation requests, negotiating the resolution of enforcement actions, and obtaining successful results for our clients.

Chambers Review

Provided by Chambers

Securities: Litigation - USA - Nationwide

Band 3

Band 3


What the Team is Known For
Goodwin demonstrates complementary litigation and M&A expertise to great effect when advising on securities disputes relating to major corporate transactions. It draws an impressive set of clients from the technology and life sciences sectors, as well as representing major financial institutions acting as underwriters. The firm offers an impressive geographical coverage, with securities litigators present in the firm's Boston, New York, DC and California offices.
Notable practitioners

Deborah Birnbach and Caroline Bullerjahn are key contacts for the firm's nationwide securities practice. They are both based in the firm's Boston office.

Work Highlights

Provided by Chambers

  • Goodwin represented Fulcrum Therapeutics and its officers in a securities class action alleging securities law violations in connection with its announcement in February 2023 that FDA issues a clinical hold regarding an Investigational New Drug application.

Strengths

Provided by Chambers

  • Goodwin consistently delivers a rare combination of legal precision, commercial pragmatism and responsiveness. Rather than relying on risk-averse boilerplate, it engages deeply with our business operations, crafting tailored solutions. The team's service levels and responsiveness in litigation are also excellent; it communicates with clarity and is quick to engage when urgent matters arise to help us stay ahead and make informed decisions with confidence.

    Securities: Litigation respondentUSA
  • The firm has a very deep bench and brings thoughtful solutions while always putting the client first.

    Securities: Litigation respondentUSA
  • Goodwin's attorneys are uniquely communicative and responsive, which is an asset for in-house attorneys. The team takes a pragmatic view of cases with an eye toward business needs, and it is clearly experienced in efficiently handling large matters. When a Goodwin attorney tells you they're an expert in a given area of law, they mean it.

    Securities: Litigation respondentUSA

Members

Provided by Goodwin Procter LLP

  • Deborah S Birnbach

    Head of Department

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership